Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Bexil Corp. (BXLC : OTC)

• Company Description    Bexil Corporation is a holding company operating businesses directly or through companies in which it has a majority or other substantial interest. It intends to acquire and/or develop one or more businesses. Bexil's preferred transaction is a management buyout. Particularly interested in a spinoff from a larger company, Bexil can provide the equity component of a leveraged buyout (LBO) financing. Based in New York, the company is evaluating opportunities to develop and acquire long-term acute care hospitals (LTACHs). Number of Employees:

• Price / Volume Information    Yesterday's Closing Price: $65.00 Daily Weekly Monthly 20 Day Moving Average: 0 shares Shares Outstanding: 0.01 (millions) Market Capitalization: $0.39 (millions) Beta: 2.09 52 Week High: $65.00 52 Week Low: $37.00 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 0.00% -1.81% 12 Week 52.94% 38.86% Year To Date -98.38% -98.55%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL - - -,- - - ph: - fax: - None None

• General Corporate Information    Officers - - - - - - - - - - - - - - - Peer Information Bexil Corp. (ASA) Bexil Corp. (DNP) Bexil Corp. (TSI) Bexil Corp. (HIS) Bexil Corp. (CXE) Bexil Corp. (CXH) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: FIN-INVEST FUND Sector: Finance CUSIP: 088577200 SIC: 6726 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/25 Next Expected EPS Date: 11/06/25 Share - Related Items Shares Outstanding: 0.01 Most Recent Split Date: 6.00 (10.00:1) Beta: 2.09 Market Capitalization: $0.39 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/06/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: 0.18 PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: 0.13 EPS Growth vs. Year Ago Period: 106.95% vs. Previous Quarter: -96.24% Sales Growth vs. Year Ago Period: 12.16% vs. Previous Quarter: 6.23% ROE 06/30/25 - - 03/31/25 - - 12/31/24 - - ROA 06/30/25 - - 03/31/25 - - 12/31/24 - - Current Ratio 06/30/25 - - 03/31/25 - - 12/31/24 - - Quick Ratio 06/30/25 - - 03/31/25 - - 12/31/24 - - Operating Margin 06/30/25 - 129.23 03/31/25 - 66.05 12/31/24 - 109.76 Net Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Pre-Tax Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Book Value 06/30/25 - - 03/31/25 - - 12/31/24 - - Inventory Turnover 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Equity 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Capital 06/30/25 - - 03/31/25 - - 12/31/24 - -

Powered by Zacks Investment Research ©